Reactive nitrogen species formation in eosinophils and imbalance in nitric oxide metabolism are involved in atopic dermatitis-like skin lesions in NC/Nga mice

Free Radical Research

Volumn 39, Issue 7, 2005, Pages 719-727

  Kubo, Masayuki ^a   Kambayashi, Yasuhiro ^a   Takemoto, Kei ^a   Okuda, Junna ^a   Muto, Masahiko ^b   Ogino, Keiki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; NC Nga mice; Nitric oxide; Nitric oxide synthase; Nitrotyrosine; Reactive nitrogen species

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; REACTIVE NITROGEN SPECIES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; EOSINOPHIL; EPIDERMIS; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PRURITUS; SKIN INFLAMMATION; UPREGULATION;

ALLERGENS; ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN; REACTIVE OXYGEN SPECIES; TYROSINE;

ANIMALIA;

EID: 21844475880     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760500139260     Document Type: Article

References (42)

1. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003;54:469-487.
2. Cals-Grierson MM, Ormerod AD. Nitric oxide function in the skin. Nitric Oxide 2004;10:179-193.
3. Hanafy KA, Krumenacker JS, Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit 2001;7:801-819.
4. Kelm M. Nitric oxide metabolism and breakdown. Biochim Biophys Acta 1999;1411:273-289.
5. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996; 271:C1424-C1437.
6. Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001;30:463-488.
7. Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, Hazen SL. A tale of two controversies: Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 2002;277:17415-17427.
8. Greenacre SA, Ischiropoulos H. Tyrosine nitration: Localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 2001;34:541-581.
9. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-160.
10. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Investig 2004;113:651-657.
11. Rowe A, Farrell AM, Bunker CB. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997;136:18-23.
12. Taniguchi Y, Kohno K, Inoue S, Koya-Miyata S, Okamoto I, Arai N, Iwaki K, Ikeda M, Kurimoto M. Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol 2003;3:1313-1324.
13. Taniuchi S, Kojima T, Hara K, Yamamoto A, Sasai M, Takahashi H, Kobayashi Y. Increased serum nitrate levels in infants with atopic dermatitis. Allergy 2001; 56:693-695.
14. Omata N, Tsukahara H, Ito S, Ohshima Y, Yasutomi M, Yamada A, Jiang M, Hiraoka M, Nambu M, Deguchi Y, Mayumi M. Increased oxidative stress in childhood atopic dermatitis. Life Sci 2001;69:223-228.
15. Kondo K, Nagami T, Tadokoro S. Differences in haematopoietic death among inbred strains of mice. In: Bond PV, Sugahara T, editors. Comparative Cellular and Species Radiosensitivity. Tokyo: Igakushoin; 1969. p 20.
16. Festing MFW. Origins and characteristics of inbred strains of mice. In: Lyon MF, Rastan S, Brown SDM, editors. Genetic Variant and Strains of the Laboratory Mouse. Oxford: Oxford University Press; 1996. p 1537.
17. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997; 9:461-466.
18. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, Imai T, Yoshie O, Irimura T, Mizutani H, Matsushima K. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Investig 1999;104:1097-1105.
19. Ogino K, Nakajima M, Kodama N, Kubo M, Kimura S, Nagase H, Nakamura H. Immunohistochemical artifact for nitrotyrosine in eosinophils or eosinophil containing tissue. Free Radic Res 2002;36:1163-1170.
20. Kodama N, Kambayashi Y, Kubo M, Nobukuni Y, Kimura S, Nakamura H, Ogino K. Induction of myeloperoxidase and nitrotyrosine formation in a human eosinophilic leukemia cell line, EoL-1. Cell Biochem Funct 2004;22:105-112.
21. Johnson GR, Metcalf D. Detection of a new type of mouse eosinophil colony by Luxol-fast-blue staining. Exp Hematol 1980;8:549-561.
22. Ishibashi T, Himeno M, Imaizumi N, Maejima K, Nakano S, Uchida K, Yoshida J, Nishio M. NO(x) contamination in laboratory ware and effect of countermeasures. Nitric Oxide 2000;4:516-525.
23. Shigenaga MK, Lee HH, Blount BC, Christen S, Shigeno ET, Yip H, Ames BN. Inflammation and NO(X)-induced nitration: Assay for 3-nitrotyrosine by HPLC with electrochemical detection. Proc Natl Acad Sci USA 1997; 94: 3211-3216.
24. Ishida N, Hasegawa T, Mukai K, Watanabe M, Nishino H. Determination of nitrotyrosine by HPLC-ECD and its application. J Vet Med Sci 2002;64:401-404.
25. Ogino K, Kodama N, Nakajima M, Yamada A, Nakamura H, Nagase H, Sadamitsu D, Maekawa T. Catalase catalyzes nitrotyrosine formation from sodium azide and hydrogen peroxide. Free Radic Res 2001;35:735-747.
26. Jorg A, Pasquier JM, Klebanoff SJ. Purification of horse eosinophil peroxidase. Biochim Biophys Acta 1982;701: 185-191.
27. Leiferman KM. A role for eosinophils in atopic dermatitis. J Am Acad Dermatol 2001;45:S21-S24.
28. Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy 2004;59:561-570.
29. Kaneko M, Swanson MC, Gleich GJ, Kita H. Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation. J Clin Investig 1995;95: 2813-2821.
30. Oshiba A, Hamelmann E, Takeda K, Bradley KL, Loader JE, Larsen GL, Gelfand EW. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J Clin Investig 1996;97:1398-1408.
31. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003;35:213-225.
32. Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 1999;274:25933-25944.
33. Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 2000;162:701-706.
34. MacPherson JC, Comhair SA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, Samoszuk MK, Hazen SL. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 2001;166:5763-5772.
35. Akaike T, Okamoto S, Sawa T, Yoshitake J, Tamura F, Ichimori K, Miyazaki K, Sasamoto K, Maeda H. 8-nitroguanosine formation in viral pneumonia and its implication for pathogenesis. Proc Natl Acad Sci USA 2003;100:685-690.
36. Alvarez B, Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 2003;25:295-311.
37. Lima ES, Di Mascio P, Abdalla DS. Cholesteryl nitrolinoleate, a nitrated lipid present in human blood plasma and lipoproteins. J Lipid Res 2003;44:1660-1666.
38. Chamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW, Williams ML, Elias PM. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: Changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002;47:198-208.
39. Aioi A, Tonogaito H, Suto H, Hamada K, Ra CR, Ogawa H, Maibach H, Matsuda H. Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br J Dermatol 2001;144:12-18.
40. Boissel JP, Ohly D, Bros M, Godtel-Armbrust U, Forstermann U, Frank S. The neuronal nitric oxide synthase is upregulated in mouse skin repair and in response to epidermal growth factor in human HaCaT keratinocytes. J Investig Dermatol 2004;123:132-139.
41. Tsuboi H, Kouda K, Takeuchi H, Takigawa M, Masamoto Y, Takeuchi M, Ochi H. 8-hydroxydeoxyguanosine in urine as an index of oxidative damage to DNA in the evaluation of atopic dermatitis. Br J Dermatol 1998;138:1033-1035.
42. Niwa Y, Sumi H, Kawahira K, Terashima T, Nakamura T, Akamatsu H. Protein oxidative damage in the stratum corneum: Evidence for a link between environmental oxidants and the changing prevalence and nature of atopic dermatitis in Japan. Br J Dermatol 2003;149:248-254.